Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others

Contributing writer

Kelsey Flood, MD
Harvard Medical School
Boston, United States

Kelsey Flood, MD is a clinical and research fellow in dermatology at Beth Israel Deaconess Medical Center and Harvard Medical School.

Last Updated: Apr 17, 2019

Kevin T. Savage, BA
Drexel University College of Medicine
Philadelphia, United States

Kevin T. Savage, BA is a rising fourth year medical student at Drexel University College of Medicine. He is currently completing a predoctoral research fellowship with Dr. Alexa B. Kimball in the Clinical Laboratory for Epidemiology and Applied Research in Skin (CLEARS) in the Department of Dermatology at Beth Israel Deaconess Medical Center.

Last Updated: Apr 16, 2019

Latest news

March 30, 2021
Learn how psoriasis severity is currently measured and why a change is necessary, how IPC organized the Delphi process that was used to redefine severity classification, implications and effects the output has on psoriasis treatment providers and psoriasis patients, and ultimately how patients will benefit from this endeavor.
March 29, 2021
Janssen Pharmaceutical Companies of Johnson & Johnson published the long-term data of the third phase of the DISCOVER-2a study.
March 28, 2021
Sun Pharmaceutical Industries Inc. announces results from their five-year Phase-3 efficacy and safety clinical trial for ILUMYA®(tildrakizumab-asmn) based on a pooled analysis of the ReSURFACE 1 and ReSURFACE 2 extension.
March 17, 2021
Update on the PsoProtect Registry. PsoProtect is a global registry for clinicians to report outcomes of COVID-19 in individuals with psoriasis. Data set currently includes 1002 cases.
  More News

We use cookies on this site to enhance your online experience. By continuing to use this site, you agree to accept cookies.
OK